Epithelial-myoepithelial carcinoma: retrospective analysis of the case series from a reference center in São Paulo, Brazil
Gabriela Miglioranza Gonçalves Luccas, Kim Soares Marinho, Lara Caroline Cardoso, Maria Paula Spegiorin de Oliveira, Renato Nobutaka Gotoda, Dorival de Carlucci Junior, Luiz Paulo Kowalski
Abstract
Introduction: Salivary gland pathologies constitute a highly heterogeneous set of diseases. Epithelial-Myoepithelial Carcinoma (EMC) is one such pathology, accounting for only 1% of cases. It is a rare and biphasic malignant neoplasm, particularly affecting the parotid gland. Its standard treatment and prognosis remain uncertain because of its low population incidence, prompting ongoing investigations. Objective: Given the recent increase in diagnoses in our service, a referral center in São Paulo, this study aims to analyze the case series at this center and compare it with the existing literature. The objective is to comprehend the characteristics and prognosis of this disease and provide insights to enhance its treatment. Methods: Confirmed cases of EMC were selected at the Hospital das Clínicas da FMUSP between 2011 and 2021. Fourteen cases were screened and subjected to retrospective analysis of medical records for data collection. Results: The analysis covered patient and disease characteristics. Of the total, 64.3% were female, with an average age of 71.33 years. The parotid gland was the predominant primary site (92.8%). Concerning staging, there was a significant prevalence in stages III and IVa. Among the cases, 12 underwent surgery, and eight patients received adjuvant therapy. Conclusion: Despite EMC being a low-grade neoplasm, our case series, while aligning with much of the existing literature, revealed a more advanced presentation. This raises questions about whether this aggressiveness is due to late diagnosis or whether the neoplasm is less indolent than presumed.
Keywords
References
1. Chaudhari P, Kaur J, Nalwa A, Suri V, Panda A, Bhasker S, Chander S. Epithelial myoepithelial carcinoma of parotid gland. Indian J Otolaryngol Head Neck Surg. 2019;71(Suppl 1):62-5. http://dx.doi.org/10.1007/s12070-016-1025-x. PMid:31741932.
2. Gore MR. Epithelial-myoepithelial carcinoma: a population-based survival analysis. BMC Ear Nose Throat Disord. 2018;18(1):15. http://dx.doi.org/10.1186/s12901- 018-0063-2. PMid:30127663.
3. Donath K, Seifert G, Schmitz R. Zur diagnose und ultrastruktur des tubulären speichelgangcarcinoms. Virchows Arch A Pathol Pathol Anat. 1972;356:16-31. http://dx.doi.org/10.1007/BF00543554. PMid:4340536.
4. Seifert G, Sobin LH. Histologic typing of salivary gland tumors. Berlin: Springer; 1991. (WHO. World Health Organization. International Histological Classification of Tumours). http://dx.doi.org/10.1007/978-3-642-84506-2.
5. Sanz Sánchez CI, Pérez Villa L, Cazorla Ramos OE. Epithelial-myoepithelial carcinoma of the base of tongue. Acta Otorrinolaringol Esp. 2021;72(3):198-200. http://dx.doi.org/10.1016/j.otorri.2020.02.006. PMid:32487431.
6. González-Ballester D, Moreno García C, González-García R, Ruiz-Laza L, Monje-Gil F. Carcinoma epitelial-mioepitelial de glándula salival menor: diagnóstico inesperado ante sospecha de patología benigna. Rev Esp Cir Oral Maxilofac. 2012;34(2):88-91. http://dx.doi.org/10.1016/j.maxilo.2011.08.003.
7. Mahdavi N, Ghorbanpour M. Epithelial-myoepithelial carcinoma of the palate: report of a case and review of the literatures. Iran J Pathol. 2020;15(2):144-50. http://dx.doi.org/10.30699/ijp.2020.105039.2076. PMid:32215030.
8. Fonseca I, Soares J. Epithelial-myoepithelial carcinoma of the salivary glands. A study of 22 cases. Virchows Arch A Pathol Anat Histopathol. 1993;422(5):389-96. http://dx.doi.org/10.1007/BF01605458. PMid:8322454.
9. Lee YS, Ha SM, Paik SW, Yang HJ, Jeon HJ, Park DJ, Hwang CS. Epithelialmyoepithelial carcinoma originating from a minor salivary gland in the nasal septum: a case report and literature review. Medicine. 2020;99(5):e19072. http://dx.doi.org/10.1097/MD.0000000000019072. PMid:32000457.
10. Oh HJ, Do NY, Kee KH, Park JH. Epithelial-myoepithelial carcinoma arising from the subglottis: a case report and review of the literature. J Med Case Rep. 2016;10(1):45. http://dx.doi.org/10.1186/s13256-016-0824-8. PMid:26922486.
11. Maahs GS, Oppermann PO, Maahs LGP, Machado G Fo, Ronchi AD. Parotid gland tumors: a retrospective study of 154 patients. Braz J Otorhinolaryngol. 2015;81(3):301-6. http://dx.doi.org/10.1016/j.bjorl.2015.03.007. PMid:25934418.
12. Bell RB, Dierks EJ, Homer L, Potter BE. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg. 2005;63(7):917-28. http://dx.doi.org/10.1016/j.joms.2005.03.006. PMid:16003616.
13. Caon J, Alexander C, Kader HA. Am J Clin Oncol. 2017;40(3):318-22. http://dx.doi. org/10.1097/COC.0000000000000155. PMid:25503425.
14. Vázquez A, Patel TD, D’Aguillo CM, Abdou RY, Farver W, Baredes S, Eloy JA, Park RCW. Epithelial-myoepithelial carcinoma of the salivary glands: an analysis of 246 cases. Otolaryngol Head Neck Surg. 2015;153(4):569-74. http://dx.doi. org/10.1177/0194599815594788. PMid:26195572.
Submitted date:
07/20/2023
Accepted date:
11/03/2023
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email